Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 21160-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#21160-1-AP, RRID:AB_10694572
- Product name
- ELOVL6 antibody
- Antibody type
- Polyclonal
- Description
- ELOVL6 antibody (Cat. #21160-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IHC, WB, ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Baicalein Prevents Fructose-Induced Hepatic Steatosis in Rats: In the Regulation of Fatty Acid De Novo Synthesis, Fatty Acid Elongation and Fatty Acid Oxidation.
NAT10: An RNA cytidine transferase regulates fatty acid metabolism in cancer cells.
Selective Inhibition of 11β-Hydroxysteroid Dehydrogenase Type 1 Attenuates High-Fat Diet-Induced Hepatic Steatosis in Mice.
Effect of Microbial Status on Hepatic Odd-Chain Fatty Acids Is Diet-Dependent.
Brg1 regulates pro-lipogenic transcription by modulating SREBP activity in hepatocytes.
Li P, Zhang R, Wang M, Chen Y, Chen Z, Ke X, Zuo L, Wang J
Frontiers in pharmacology 2022;13:917329
Frontiers in pharmacology 2022;13:917329
NAT10: An RNA cytidine transferase regulates fatty acid metabolism in cancer cells.
Dalhat MH, Mohammed MRS, Alkhatabi HA, Rehan M, Ahmad A, Choudhry H, Khan MI
Clinical and translational medicine 2022 Sep;12(9):e1045
Clinical and translational medicine 2022 Sep;12(9):e1045
Selective Inhibition of 11β-Hydroxysteroid Dehydrogenase Type 1 Attenuates High-Fat Diet-Induced Hepatic Steatosis in Mice.
Li H, Sheng J, Wang J, Gao H, Yu J, Ding G, Ding N, He W, Zha J
Drug design, development and therapy 2021;15:2309-2324
Drug design, development and therapy 2021;15:2309-2324
Effect of Microbial Status on Hepatic Odd-Chain Fatty Acids Is Diet-Dependent.
Weitkunat K, Bishop CA, Wittmüss M, Machate T, Schifelbein T, Schulze MB, Klaus S
Nutrients 2021 May 4;13(5)
Nutrients 2021 May 4;13(5)
Brg1 regulates pro-lipogenic transcription by modulating SREBP activity in hepatocytes.
Li N, Li M, Hong W, Shao J, Xu H, Shimano H, Lu J, Xu Y
Biochimica et biophysica acta. Molecular basis of disease 2018 Sep;1864(9 Pt B):2881-2889
Biochimica et biophysica acta. Molecular basis of disease 2018 Sep;1864(9 Pt B):2881-2889
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Raji cells were subjected to SDS PAGE followed by western blot with 21160-1-AP(ELOVL6 antibody) at dilution of 1:800
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human hepatocirrhosis using 21160-1-AP(ELOVL6 antibody) at dilution of 1:100 (under 10x lens)
- Sample type
- tissue
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The ELOVL6 antibody from Proteintech is a rabbit polyclonal antibody to a fusion protein of human ELOVL6. This antibody recognizes human, mouse, rat antigen. The ELOVL6 antibody has been validated for the following applications: ELISA, WB, IHC analysis.
